Aligos Therapeutics, Inc. Common Stock (NASDAQ: ALGS) last traded at $6.67, up 3.57% on the session. The quote above updates while this page is open; the figures below are drawn from Aligos Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aligos Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ALGS. Its market capitalisation is $41.60 million.
Valuation measures for Aligos Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $41.60M |
|---|---|
| Enterprise value | $45.66M |
| Price / sales | 11.12 |
| Price / book | 1.30 |
| Beta | 1.38 |
Trailing-twelve-month figures tagged in Aligos Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.74M |
|---|---|
| Net income (TTM) | -$75.96M |
| Operating margin | -2112.14% |
| Return on equity | -238.24% |
| Cash | $30.38M |
Range and volume for ALGS over the past 52 weeks.
| 52-week high | $13.69 |
|---|---|
| 52-week low | $3.98 |
| Volume | 51.2K |
| Average volume | 178.4K |
| Previous close | $6.44 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.